Abstract:
The present invention relates to a composition for promoting the differentiation of human mesenchymal stem cells into adipocytes. More specifically, the present invention relates to a composition for cosmetics or plastic surgery which increases the sense of volume of specific body part by creating lipid droplets by comprising at least one species among Castaneae semen, Selaginella tamariscina, Aloe vera, Salvia miltiorrhiza, Mentha arvensis, Pinellia ternate, Triticum aestivum, Saururus chinensis, Polygala tenuifolia, and Gleditsia sinensis extracts as an active ingredient to promote the differentiation of human mesenchymal stem cells into adipocytes.
Abstract:
본 발명은 인간 중간엽줄기세포의 지방세포로의 분화를 촉진하는 조성물에 관한 것으로, 보다 상세하게는 계혈등, 고량강, 독활 및 천련자 추출물 중 적어도 1종 이상을 유효성분으로 함유하여 인간 중간엽줄기세포를 지방세포로 분화하는 것을 촉진시킴으로써 지방체(Lipid droplet)를 생성하여 피부의 볼륨과 탄력을 증진시키고 주름을 개선시키는 조성물에 관한 것이다. 계혈등 * 고량강 * 독활 * 천련자 * 중간엽 줄기세포 분화 * 지방세포생성
Abstract:
본 발명은 피부 미용 및 성형용 조성물에 관한 것으로, 보다 상세하게는 백화사설초 추출물을 유효성분으로 함유하여 사람 중간엽줄기세포를 지방세포로 분화하는 것을 촉진시킴으로써 지방세포를 생성하여 피부의 볼륨과 탄력을 부여하는 미용 또는 성형 조성물에 관한 것이다. 백화사설초 * 중간엽 줄기세포 분화 * 지방세포생성
Abstract:
PURPOSE: A medicinal composition for preventing or treating diabetes and plastic surgery is provided to promote adipocyte differentiation and to enhance volume and elasticity of skin. CONSTITUTION: A medicinal composition for promoting differentiation of adipocytes contains (-)catechin, (-)epicatechin gallate, or (-)gallocatechin as an active ingredient. Adipocyte is human bone marrow mesenchymal stem cell. The (-)catechin, (-)epicatechin gallate, or (-)gallocatechin is isolated from green tea. A medicinal composition for treating and preventing type II diabetes and diabetes complication contains the (-)catechin, (-)epicatechin gallate, or (-)gallocatechin.
Abstract:
PURPOSE: A pharmaceutical composition for suppressing adipocyte differentiation and reducing lipid droplet is provided to prevent or treat obesity or lipoma. CONSTITUTION: A pharmaceutical composition of adipocyte differentiation contains arachidonyl dopamine. The pharmaceutical composition prevents adipose tissue enlargement-related disease. The adipose tissue enlargement-related disease is obesity or lipoma. The differentiation of adipocyte is from mesenchymal stem cell to adipocyte. The mesenchymal stem cell is human bone marrow mesenchymal stem cell. A formulation of oral administration is used in the form of pill, powder, suspension, emulsion, syrup, and granule.